EHC

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?

Encompass Health Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.

Encompass Health's capacity expansion, new facilities and North Carolina pipeline could fuel 6-8% multi-year discharge growth.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The transaction realized approximately $1.1 million at a weighted average price of $125.95 per share. The executive reduced his direct common stock holdings by 11% through this open-market sale.

Coltharp executed the sale of 18,869 shares at a weighted average price of $125.38 per share on August 10. The transaction reduced the executive's direct equity position by 27%, while his total beneficial ownership decreased by 7%.

The transaction involved 173,148 shares sold at a weighted average price of $125.47, totaling approximately $21.7 million. This disposition represents 39% of the CEO's direct common stock holdings in the company.